Sign Up to like & get
recommendations!
0
Published in 2018 at "Psychiatry and Clinical Neurosciences"
DOI: 10.1111/pcn.12679
Abstract: Schizophrenia (SCZ) is a heterogeneous disease with approximately 10% of patients initially diagnosed with schizophrenia having autoantibodies binding to the NMDA receptor and presenting as anti-NMDAR encephalitis.1 Therefore, immune modulating therapy may frequently respond well…
read more here.
Keywords:
modulating therapy;
encephalitis;
receptor;
immune modulating ... See more keywords